By inhibiting the PI3K/AKT and TLRs/NF-κB signaling pathways, reducing the secretion of inflammatory factors and inhibiting hepatocyte apoptosis, thereby alleviating the inflammatory response in autoimmune hepatitis (AIH). The gene discussed is AKT1; the disease is autoimmune hepatitis.